Purchase Order SPE2DS19V9389
- Not listed
- This federal contract award, valued at $1,486.54, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of "WASHING SOLUTION,FR" and is a firm fixed-price purchase order with a completion date of July 23, 2025. Fenwal, Inc. is a registered vendor with the U.S. federal government, having maintained its registration since April 3, 2007, and has...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
- This federal contract award, valued at $1,426.36, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various medical supplies and equipment, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The contract does not have a set-aside designation, reflecting Fenwal's...
- This federal contract award, with ID SPE2DP23P0467, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $3,510.90 firm fixed-price purchase order is for the supply of washing solution, a specialized medical product used in healthcare and biomedical research initiatives. The contract has no set-aside designation and supports critical defense medical supply chains. Fenwal, Inc. is...
- This federal contract award, valued at $3,297.19, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of a Diluting Solution, which is a specialized medical supply that supports healthcare and biomedical research initiatives. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Fenwal's competitive capabilities in the federal procurement...
- This federal contract award from the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, is for the supply of washing solution for medical use. The $2,317.68 firm fixed-price purchase order has a period of performance through March 4, 2024. Fenwal, Inc. is a registered vendor with the U.S. federal government, having maintained its registration since April 3, 2007. The company has consistently secured federal contract awards from...
- The U.S. Defense Logistics Agency awarded a $2,188.92 firm fixed-price purchase order to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the supply of "Washing Solution, FR" to support the agency's medical supply chain operations. This award does not have a set-aside designation. Fenwal has extensive experience providing a wide range of medical supplies and equipment, including blood bags, tubing, solutions, and specialized items,...
- This federal contract award, number SPE2DP24P0460, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi that specializes in blood collection, separation, storage, and transfusion products and services. The $10,300.80 firm-fixed-price purchase order is for the delivery of washing solution, which is likely to support transfusion medicine and cell therapy applications for the Department of Defense and other federal agencies....
- This federal contract award is for a purchase order with Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, to provide a washing solution, FR (Federal Requirement). The contract has a firm fixed price of $1,351.40 and an ultimate completion date of September 8, 2025. The contract was awarded on July 8, 2025 by the Defense Logistics Agency (DLA), which is a defense agency. Fenwal, Inc. is a registered vendor with the U.S. federal government and has previously...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and consumables for the blood and biomedical research supply chain. The $1,148.65 contract is for the supply of blood collection assemblies and related products to support critical healthcare programs, including military medical supply chains and biomedical research initiatives. The contract has an ultimate...
This federal contract award, valued at $2,570.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is a firm fixed-price purchase order for the supply of specialized medical products, such as blood collection assemblies, washing solutions, and apheresis equipment, to support critical healthcare programs, including military medical supply chains, biomedical research initiatives, and blood banking operations. The contract does not have a set-aside designation, indicating Fenwal's competitive capabilities across federal procurement landscapes. Fenwal has consistently secured federal contract awards from multiple agencies, including the DLA, National Institutes of Health (NIH) Clinical Center, Defense Health Agency, and Department of Veterans Affairs, demonstrating its role as a critical supplier of specialized medical equipment and consumables to the U.S. government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/9/19 |